COG RESEARCH FOUNDATION LLC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2024

Legal Domicile

Principal Officer

DOUGLAS S HAWKINS MD

Phone

2672777064

Tax Period

2024-06-01 to 2025-05-31

COG RESEARCH FOUNDATION LLC, founded in 2024, is a community nonprofit in the Medical Research sector that reported $1.4M in total revenue in fiscal year 2024. Expenses of $1.2M left a modest 12% surplus.

Mission

COG RESEARCH FOUNDATION, LLC IS A CALIFORNIA 501(C)(3) ENTITY FOUNDED IN 2024 AND DESIGNED TO BECOME THE FEDERAL GRANTEE ORGANIZATION FOR THE CHILDREN'S ONCOLOGY GROUP (COG). THE COG, A MEMBER OF THE NATIONAL CANCER INSTITUTE (NCI) NATIONAL CLINICAL TRIALS NETWORK (NCTN), IS THE WORLD'S LARGEST ORGANIZATION DEVOTED EXCLUSIVELY TO CHILDHOOD AND ADOLESCENT CANCER RESEARCH.

Program Service Accomplishments

Program 1

Expenses: $1,216,276

COG RESEARCH FOUNDATION, LLC PROVIDES ADMINISTRATIVE, AS WELL AS STATISTICAL AND DATA MANAGEMENT SUPPORT FOR THE CHILDREN'S ONCOLOGY GROUP (COG). THE COG, A CLINICAL TRIALS GROUP SUPPORTED BY THE...

COG RESEARCH FOUNDATION, LLC PROVIDES ADMINISTRATIVE, AS WELL AS STATISTICAL AND DATA MANAGEMENT SUPPORT FOR THE CHILDREN'S ONCOLOGY GROUP (COG). THE COG, A CLINICAL TRIALS GROUP SUPPORTED BY THE NATIONAL CANCER INSTITUTE, IS THE WORLD'S LARGEST ORGANIZATION DEVOTED EXCLUSIVELY TO CHILDHOOD AND ADOLESCENT CANCER RESEARCH. COG BRINGS TOGETHER MORE THAN 10,000 EXPERTS IN CHILDHOOD CANCER AT MORE THAN 200 INSTITUTIONS. THEY SUPPORT CLINICAL RESEARCH TRIALS THAT STUDY AND DETERMINE THE UNDERLYING BIOLOGY OF CHILDHOOD CANCERS, EMERGING TREATMENTS, SUPPORTIVE CARE, AND SURVIVORSHIP, AND CARE FOR 80-90% OF THE 13,500 CHILDREN AND ADOLESCENTS DIAGNOSED WITH CANCER EACH YEAR.COG IS STRUCTURED TO MAXIMIZE EFFICIENCY, PROMOTE COLLABORATION, AND RETAIN THE FLEXIBILITY TO FOCUS RESOURCES ON THE MOST PROMISING SCIENTIFIC ADVANCES. EXTENSIVE COLLABORATION AND INTEGRATION ARE FOUND THROUGHOUT COG'S ORGANIZATION. THE CHILDREN'S ONCOLOGY GROUP HAS OVER 50 ACTIVE CLINICAL TRIALS OPEN AT ANY GIVEN TIME. THESE TRIALS INCLUDE FRONT-LINE TREATMENT FOR MANY TYPES OF CHILDHOOD CANCERS, STUDIES AIMED AT DETERMINING THE UNDERLYING BIOLOGY OF THESE DISEASES, AND TRIALS INVOLVING NEW AND EMERGING TREATMENTS, SUPPORTIVE CARE, AND SURVIVORSHIP. THE CHILDREN'S ONCOLOGY GROUP RESEARCH HAS TURNED CHILDREN'S CANCER FROM A VIRTUALLY INCURABLE DISEASE 50 YEARS AGO TO ONE WITH A COMBINED 5-YEAR SURVIVAL RATE OF 86% TODAY. OUR GOAL IS TO CURE ALL CHILDREN AND ADOLESCENTS WITH CANCER, REDUCE THE SHORT AND LONG-TERM COMPLICATIONS OF CANCER TREATMENTS, AND DETERMINE THE CAUSES AND FIND WAYS TO PREVENT CHILDHOOD CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,417,189

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $1,417,189

Expense Breakdown

Grants Paid $0

Salaries & Benefits $271,222

Fundraising Expenses $0

Program Expenses $1,216,276

Other Expenses $978,694

TOTAL EXPENSES $1,249,916

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,417,189	N/A	N/A
Expenses	$1,249,916	N/A	N/A
Net Income	$167,273	$0	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$119,097

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DOUGLAS S HAWKINS MD	PRESIDENT	2.00	Officer Director	$0	$0	$0
LIA GORE MD	MEMBER	2.00	Director	$0	$0	$0
ELIZABETH RAETZ MD	MEMBER	0.50	Director	$0	$0	$0
LEO MASCARENHAS MD MS	MEMBER	0.50	Director	$0	$0	$0
CINDY L SCHWARTZ MD MPH	MEMBER	0.50	Director	$0	$0	$0
JASON A JARZEMBOWSKI MD PHD	MEMBER	0.50	Director	$0	$0	$0
DEBORAH L CRABTREE	EXECUTIVE VP & TREASURER	2.00	Officer	$0	$0	$0
RONALD WILSON JD	VICE PRESIDENT, SECRETARY	2.00	Officer	$0	$0	$0
JOHN PLUNKETT	ASSISTANT TREASURER	2.00	Officer	$0	$0	$0
DANIEL T WOODS	ASST VP & ASST SECRETARY	2.00	Officer	$0	$14,058	$119,097

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,417,189	$1,249,916	$593,097	$167,273